Author Information
Anis Feki is affiliated with the Service de gynécologie obstétrique at HFR Fribourg - Hôpital cantonal in Fribourg, Switzerland, and the Stem Cell Research Laboratory, Department of Obstetrics and Gynecology, Geneva University Hospitals, Geneva, Switzerland.Research Contributions
Anis Feki has made significant contributions to the field of gynecology, with a focus on various aspects such as ovarian tumors, endometriosis, adenomyosis, stress urinary incontinence, and maternal outcomes in the context of COVID-19. In 2021, Feki published numerous impactful papers, including studies on serous borderline ovarian tumor diagnosis and management, antiangiogenic therapy for endometriosis, training of clinicians, metformin as a potential therapy for endometriosis, current treatments for adenomyosis, and new surgical treatments for stress urinary incontinence. Additionally, Feki has explored maternal outcomes and risk factors for COVID-19 severity among pregnant women and the clinical impact of low-volume lymph node metastases in early-stage cervical cancer. An innovative study on the interactome analysis of iPSC secretome and its effects on macrophages in vitro is also part of Feki's 2021 research portfolio.Aliases
The following aliases are associated with Anis Feki: A Feki, A. Feki, and Anis Féki.Publication and Citation Metrics
| Citation Count |
3253 |
| h-index |
31 |
| Paper Count |
139 |
